{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:16:48Z","timestamp":1791220608113,"version":"4.1.0"},"reference-count":92,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2015,5,4]]},"DOI":"10.1517\/14712598.2015.1025047","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T01:32:00Z","timestamp":1426210320000},"page":"651-664","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":39,"title":["Histone deacetylation meets miRNA: epigenetics and post-transcriptional regulation in cancer and chronic diseases"],"prefix":"10.1517","volume":"15","author":[{"given":"Stefan","family":"Swierczynski","sequence":"first","affiliation":[{"name":"Paracelsus Medical University, Salzburger Landeskliniken, Department of Surgery","place":["Austria"]},{"name":"Paracelsus Medical University, Salzburger Landeskliniken, Institute of Pathology","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Klieser","sequence":"additional","affiliation":[{"name":"Paracelsus Medical University, Salzburger Landeskliniken, Institute of Pathology","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"Illig","sequence":"additional","affiliation":[{"name":"Paracelsus Medical University, Salzburger Landeskliniken, Institute of Pathology","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Alinger-Scharinger","sequence":"additional","affiliation":[{"name":"Paracelsus Medical University, Salzburger Landeskliniken, Institute of Pathology","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Kiesslich","sequence":"additional","affiliation":[{"name":"Paracelsus Medical University, Institute of Physiology and Pathophysiology","place":["Austria"]},{"name":"Paracelsus Medical University, Salzburger Landeskliniken, Department of Internal Medicine I","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Neureiter","sequence":"additional","affiliation":[{"name":"Paracelsus Medical University, Salzburger Landeskliniken, Institute of Pathology","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,3,12]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2007.01.001"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2012.28"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature13714"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02479423"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2010.136"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/35404"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.250477697"},{"key":"e_1_3_2_10_1","first-page":"3697","article-title":"Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial\/cytochrome c-dependent pathway","volume":"57","author":"Medina V","year":"1997","unstructured":"Medina V, Edmonds B, Young GP, et al. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial\/cytochrome c-dependent pathway. Cancer Res 1997;57:3697-707","journal-title":"Cancer Res"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.9067"},{"key":"e_1_3_2_12_1","first-page":"214143","article-title":"Myelodysplastic syndrome and histone deacetylase inhibitors: \u201cto be or not to be acetylated\u201d?","volume":"2011","author":"Stintzing S","year":"2011","unstructured":"Stintzing S, Kemmerling R, Kiesslich T, et al. Myelodysplastic syndrome and histone deacetylase inhibitors: \u201cto be or not to be acetylated\u201d? J Biomed Biotechnol 2011;2011:214143","journal-title":"J Biomed Biotechnol"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0803055105"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1773"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.08.016"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2013.05.020"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.300415"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijdevneu.2013.02.005"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S37750"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2013.853076"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27876"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2012.07.003"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-394494"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.25088"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.19"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.148"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024099"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt346"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-013-1762-z"},{"key":"e_1_3_2_30_1","doi-asserted-by":"crossref","unstructured":"Wang Y Toh HC Chow P et al. MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms. FASEB J. 2012;26(7):3032-41","DOI":"10.1096\/fj.11-201855"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1213764109"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.192625"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073589"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.2217\/epi.13.73"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39832"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq083"},{"key":"e_1_3_2_37_1","doi-asserted-by":"crossref","unstructured":"Huang S Wang S Bian C et al. Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression. Stem Cells Dev. 2012;21(13):2531-40","DOI":"10.1089\/scd.2012.0014"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64210"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.02.032"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i42.4711"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310876200"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09673"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00969-13"},{"issue":"4","key":"e_1_3_2_44_1","first-page":"277","article-title":"[Genetic pathways in colorectal cancer: interest for the pathologist]","volume":"22","author":"Piard F","year":"2002","unstructured":"Piard F, Martin L, Chapusot C, et al. [Genetic pathways in colorectal cancer: interest for the pathologist]. Ann Pathol 2002;22(4):277-88","journal-title":"Ann Pathol"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1385806"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.300415"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203450"},{"issue":"4","key":"e_1_3_2_48_1","first-page":"129","article-title":"The development and potential clinical utility of biomarkers for HDAC inhibitors","volume":"7","author":"Shi B","year":"2013","unstructured":"Shi B, Xu W. The development and potential clinical utility of biomarkers for HDAC inhibitors. Drug Discov Ther 2013;7(4):129-36","journal-title":"Drug Discov Ther"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2012.09.003"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.234468.113"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2014.01.032"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2012.08.058"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-0284-9_28"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/1868-7083-4-5"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S29965"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2011.01.021"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076540"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00207.2010"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006816"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.148"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2012.10.023"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2013.125"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-013-1938-6"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.300989"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1301693110"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.140"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.450"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076540"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep06145"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29140"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1301693110"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2010.10.008"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.279836"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.140"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4092"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.12.3"},{"issue":"4","key":"e_1_3_2_78_1","first-page":"129","article-title":"The development and potential clinical utility of biomarkers for HDAC inhibitors","volume":"7","author":"Shi B","year":"2013","unstructured":"Shi B, Xu W. The development and potential clinical utility of biomarkers for HDAC inhibitors. Drug Discov Ther 2013;7(4):129-36","journal-title":"Drug Discov Ther"},{"issue":"6","key":"e_1_3_2_79_1","first-page":"1343","article-title":"MicroRNAs that respond to histone deacetylase inhibitor SAHA and p53 in HCT116 human colon carcinoma cells","volume":"35","author":"Shin S","year":"2009","unstructured":"Shin S, Lee EM, Cha HJ, et al. MicroRNAs that respond to histone deacetylase inhibitor SAHA and p53 in HCT116 human colon carcinoma cells. Int J Oncol 2009;35(6):1343-52","journal-title":"Int J Oncol"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/mc.21879"},{"issue":"1","key":"e_1_3_2_81_1","first-page":"45","article-title":"Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cells","volume":"24","author":"Lee EM","year":"2009","unstructured":"Lee EM, Shin S, Cha HJ, et al. Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cells. Int J Mol Med 2009;24(1):45-50","journal-title":"Int J Mol Med"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2012.09.003"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.140"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-480400"},{"issue":"54","key":"e_1_3_2_85_1","first-page":"462","article-title":"Histone deacetylase inhibitors in the treatment of lymphoma","volume":"10","author":"Lemoine M","year":"2010","unstructured":"Lemoine M, Younes A. Histone deacetylase inhibitors in the treatment of lymphoma. Discov Med 2010;10(54):462-70","journal-title":"Discov Med"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083018"},{"key":"e_1_3_2_87_1","article-title":"The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines","author":"Henrici A","year":"2013","unstructured":"Henrici A, Montalbano R, Neureiter D, et al. The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines. Mol Carcinog 2013. [Epub ahead of print]","journal-title":"Mol Carcinog"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-351510"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082895"},{"issue":"3","key":"e_1_3_2_90_1","first-page":"316","article-title":"Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia","volume":"4","author":"Hunsberger JG","year":"2012","unstructured":"Hunsberger JG, Fessler EB, Wang Z, et al. Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia. Am J Transl Res 2012;4(3):316-32","journal-title":"Am J Transl Res"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2013.10.001"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.01.018"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.79"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/923824"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14712598.2015.1025047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T19:06:15Z","timestamp":1770404775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14712598.2015.1025047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,12]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5,4]]}},"alternative-id":["10.1517\/14712598.2015.1025047"],"URL":"https:\/\/doi.org\/10.1517\/14712598.2015.1025047","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-03-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}